TFTC Podcast #587: The Report on mRNA-Triggered Cancers with Kevin McKernan
Host: Marty Bent
Guest: Kevin McKernan
Date: February 19, 2025
Overview
This episode brings back genomics researcher Kevin McKernan for a follow-up discussion focused on the latest data and research around mRNA COVID-19 vaccines, with special emphasis on recently published (preprint) findings indicating excess cancer mortality and shifts in cancer profiles in Japan. The conversation is set against the broader backdrop of changing political, regulatory, and public health landscapes, and it explores the intersection of government incentives, pharmaceutical influence, Bitcoin as an alternative system, and the tension between innovation and accountability in health care.
Key Discussion Points & Insights
1. Political and Regulatory Shifts in 2024-2025
- Changing Landscape: Kevin and Marty reflect on how the world, especially the regulatory and political climate, has shifted dramatically since early 2024.
- “The tides have changed drastically, particularly from the regulatory perspective on the industry.” — Kevin McKernan [01:20]
- RFK Jr. at HHS: Surprise at RFK Jr.’s appointment at HHS and the implications for vaccine policy and pharma oversight.
- Potential Directions: Skepticism remains on whether the new administration will meaningfully address vaccine mandates, transparency, and pharma-industry conflicts.
2. Pharma Influence and COVID-19 Vaccine Rollout
- Operation Warp Speed: Discussion of the original intent (rapid response, off-patent drugs) vs. what actually happened (pharma favoring vaccines for profits).
- “What I don’t want out of all this is, we gotta make the FDA bigger to make sure the FDA doesn’t do this again, which is where that can go.” — Unidentified Expert [02:07]
- Conflict of Interest: The NIH received $1.2 billion in royalties for vaccines, incentivizing a singular solution.
- “NIH has $1.2 billion now in royalty for the vaccines.” — Unidentified Expert [07:51]
3. MRNA Vaccines, Immune System Effects, and Cancer Trends
- Japan as a Case Study: Review of the preprint “Miche paper” showing excess cancer mortality after mRNA vaccine rollout. The unusual scale of vaccination (seven doses common among elderly, ~80% population coverage).
- “Their excess mortality now dwarfs a tsunami…this is bigger than Hiroshima.” — Unidentified Expert [15:53]
- Cancer Profile Switching: Pre-vaccine, dominant cancers were lung, colorectal, stomach, and liver. Post-vaccine, these shift to ovarian, prostate, leukemia, pancreatic, and oral/pharyngeal, suggesting a possible link to vaccine-induced biology.
- “The types of cancer have completely changed. That’s a sign of a new toxin.” — Unidentified Expert [15:53]
- Mechanistic Plausibility: Potential mechanisms include IGG4 class switch, spike protein effects on estrogen receptors, DNA contamination, and impact on P53 and BRCA1 genes.
- “It’s a Swiss army knife of cancer.” — Unidentified Expert [22:22]
- Dose Response: Excess mortality and changes in cancer profile correlate temporally and dose-dependently with vaccine uptake.
4. Supplementary Data & Bradford Hill Criteria
- Orthogonal Evidence: Ed Dowd’s insurance data, pharmaceutical revenue increases for blood cancer drugs, and pharma M&A all align with observed cancer trends and support concerns.
- “You can dissect the pharmaceutical revenue streams…and they do [align].” — Unidentified Expert [32:23]
- AI Analysis: Feeding study data into ChatGPT initially yields “consensus” safety statements, but when prompted with detailed stats, AI shifts its risk assessment.
- “If you feed papers like this into ChatGPT…its initial response will probably be, based on what it's reading in the news, safe and effective...But you can eventually get ChatGPT to come to the conclusion that this is a train wreck and it needs to be pulled.” — Unidentified Expert [15:53 and 22:12]
5. Wider Societal and Systemic Implications
- Fiat Incentives and Pharma Profits: The profit motive drives development and persistent use of vaccines and subsequent therapies, creating a “positive feedback loop for them and a negative one for us.” — Unidentified Expert [10:46]
- Possible Social Security Motives: The guest speculates on demographic and fiscal incentives for government/pharma to lower life expectancy in costly age groups. [35:14]
- Erosion of Trust in Public Health and Regulatory Bodies: Cites pharma donations to politicians, journalistic conflicts, and lack of regulatory accountability as sources for skepticism. [68:39]
6. Drug War, Cannabis, Psychedelics, and Medical Innovation
- Medical Cannabis & Psychedelics: Advocacy for further research/application, highlighting their potential to address opioid addiction, depression, and even cancer.
- “Make America Healthy Again can’t just be about nutrition. It’s got to be about medical death...iatrogenic death.” — Unidentified Expert [45:07]
- Hemp “Loophole” and Market Chaos: Fascinating detour into the proliferation and risks of unregulated cannabinoid products. Mitch McConnell’s legalization of hemp leading to wild-west pseudo-cannabis market (e.g. Delta-8, THCP) [47:10 – 53:29]
- Perverse Incentives: Pharma’s interest in stoking chaos in the hemp market as a means of undermining broader cannabis legalization and competition.
7. The Role of Free Markets and Bitcoin
- Bitcoin as Alternative: Parallels drawn between fiat corruption in pharma/medicine and the hard-money ethos of Bitcoin.
- Market Solutions: Hope for “medical free zones,” decentralized health data, and emerging non-FDA solutions for wellness and “despiking” the body after mRNA vaccines.
Notable Quotes & Memorable Moments
-
On the new regulatory winds:
“If you would have told me 11 months ago that the landscape would be as it is today, I would be like, ‘ah, you’re crazy.’” — Kevin McKernan [01:20] -
On the cancer study in Japan:
“Their excess mortality now dwarfs a tsunami…this is bigger than Hiroshima.” — Unidentified Expert [15:53] -
On the pharma business model:
“It’s this conveyor belt of crime. Manufacture the crisis and come and have the solution ready for it…to treat the mess they created with the mRNA vaccines. It’s one large fiat grift.” — Unidentified Expert [33:18] -
On government and corporate incentives:
“When the government is control of your death date and they’re also in control of your retirement, bad outcomes will emerge.” — Unidentified Expert [35:14] -
On AI and medical consensus:
“If you feed papers like this into ChatGPT…its initial response will probably be, based on what it's reading in the news, safe and effective...But you can eventually get ChatGPT to come to the conclusion that this is a train wreck and it needs to be pulled.” — Unidentified Expert [22:12] -
On iatrogenic death:
“Medical death. And some of that starts with the opiate epidemic…But there’s loads of literature out there on people reducing their opiate intake by replacing it with cannabinoids.” — Unidentified Expert [45:23] -
On FDA capture:
“When you look into their funding, you realize through the PDUFA act of 92, they're not a regulator, they're a marketing arm, a Pfizer.” — Unidentified Expert [70:11] -
On SSRIs and mass shootings:
“If they're not overt false flags planned by the FBI, they're driven by SSRIs that drive people suicidal and murderous.” — Kevin McKernan [75:29] -
On political corruption:
“I always knew they were getting bought by pharma. I just didn’t realize how cheap their price was… one and a half million dollars to buy.” — Paraphrasing Elgato Malo via Unidentified Expert [68:39]
Timestamps for Important Segments
- 00:36 – 02:07: Change in political landscape, RFK Jr. at HHS, initial take on mRNA controversy
- 06:04 – 09:44: High-level pharma/corporate conflicts, sovereign wealth fund backing vaccines, evidence of regulatory capture
- 11:13 – 15:53: Deep-dive into the Japanese cancer mortality study and the implications for vaccine safety
- 19:50 – 23:14: Shift in cancer types post-vaccine, mechanistic paths for vaccine-driven cancer
- 30:24 – 33:15: Corroborating evidence from insurance, pharma revenues, and sales data
- 35:14 – 38:09: Discussion on perverse government incentives related to population control and finance
- 45:07 – 48:56: Expansion into opioid crisis, cannabinoids, and FDA-directed drug wars
- 52:59 – 55:08: Hemp “red state” loophole and risks of untested kitchen cannabinoids
- 70:11 – 72:36: Regulatory capture, potential for free-market solutions in medicine
- 75:29 – 77:58: SSRIs, mental health, and mass shootings
- 79:06 – End: Reflections on technology, decentralization, optimism for change, Bitcoin’s community dynamic
Flow & Tone
The conversation is fluid, wide-ranging, and candid. Marty and Kevin move seamlessly from technical analysis to broader societal questions, always employing a skeptical but data-driven tone. While focused on the science and recent evidence, the discussion is laced with sharp critique of regulatory failure, political capture, and misplaced incentives. Both speakers are passionate about transparency, health freedom, and the ethical dilemmas at the heart of modern medicine.
Conclusion
This episode provides a comprehensive, critical, and occasionally provocative examination of the emerging evidence linking mRNA vaccines to excess cancer mortality, using Japan as a high-compliance case study. It contextualizes these findings within larger systemic flaws in the health and regulatory systems, explores the risks of “positive feedback loops” in pharma’s business model, and calls for greater transparency, decentralization, and genuine preventative healthcare. Listeners are left challenged to question consensus narratives—on vaccines and far beyond.